Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 10,435 shares at $30.33 ($317K) on 2025-03-03, disclosed to the SEC on 2025-03-03.
Seasonal sale ($317k) by Chief Medical Officer — this insider has traded KYMR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.33 | 4,695 | $142K | 44.9% |
| 2 | $30.33 | 4,695 | $142K | 44.9% |
| 3 | $31.00 | 1,045 | $32K | 10.2% |
| Total | $30.40 avg | 10,435 | $317K | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2024-07-16 | $3.6M | — | Filing → |